This compound is handled exclusively in controlled research settings for in vitro and pre-clinical studies, with no applications in human or veterinary medicine
Consult with a physician before starting any new health protocol.
After coating, each well was then incubated with biotin-BPC 157 and the first antibody, goat-anti-human-IgG-Fc-biotin (Abcam), followed by the second antibody, streptavidin-HRP
It is not a dosing recommendation or a published clinical protocol
Too aggressive, and side effects become intolerable
Gastric Ulcers and GI Disorders Animal models have shown that BPC-157 can enhance the healing of gastric ulcers, and there is hope that it could be used to treat other GI issues like Crohn's disease, ulcerative colitis, and leaky gut syndrome